With the widespread use of highly active anti-retroviral treatment (HAART), HIV has become a chronic, rather than a fatal, disease.
In summary, medical providers should universally screen adolescents, adults, and pregnant women for HIV. The symp- tom of infected elderly patients, ... 2005–2006 Medical Management of HIV Infection. Baltimore: Johns Hopkins Medicine ...
REFERENCES Abadia- Barrero, C. E., 2004 Happy children with AIDS: The paradox of a healthy national program in an unequal and exclusionary Brazil. ... Bartlett, J. G., and Gallant, G., 2005 Medical Management of HIV Infection 2005–2006.
Evans D, Fitzgerald M. (2002). The experience of physical restraint: A systematic review of qualitative research. Contemp Nurse, 13(2-3):126-135. Evans D, Wood J, Lambert L. (2002a). Physical restraint—Part 1: Use in acute and ...
E. Continue to monitor glucose levels as necessary; patients taking oral antiglycemic agents should be closely followed for 24 to 48 hours. BIBLIOGRAPHY Barkley TW Jr: ... Fitzgerald PA: Endocrinology. In Tierney LM, editor: Current ...
Recognition and study of the types of infections that occur in the immunocompromised person have led to a greater understanding of ... Clinical Microbiology and Infection, 11, 427–429. ... 2005–2006 medical management of HIV infection.
Figure 4 summarizes our current understanding of Vpu‐mediated degradation of CD4. According to this model, phosphorylated Vpu ... Vpu acts as an adaptor molecule to connect the CD4 cytoplasmic domain to an (SCFTrCP) E3 complex.
Last accessed: 29 Sept 2006 Antiretroviral therapy. In: Bartlett, J.G., Gallant, J.E. (eds.) Medical Management of HIV Infection. Johns Hopkins Medicine Health Publishing Business Group, Baltimore (2005–2006) Scaling up antiretroviral ...
Natural history of untreated HIV infection. (Source: Bartlett JG, Gallant JE. 2005–2006 Medical Management of HIV Infection. Baltimore, MD: Johns Hopkins Medicine Health Publishing Business Group; 2005.) Table 7.2.
Partner reduction is crucial for balanced “ABC” approach to HIV prevention. BMJ. 2004;328:891–894. Parkhurst JO. The Ugandan success story? Evidence and claims of HIV-1 prevention. Lancet. 2002;360:78–80. General Accounting Office.